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Spastic Paraplegia and OXPHOS Impairment
Caused by Mutations in Paraplegin,
a Nuclear-Encoded Mitochondrial Metalloprotease
is a genetically heterogeneous group of neurodegenera-
tive disorders affecting approximately 1 in 10,000 indi-
viduals (Filla et al., 1992; Polo et al., 1993). Patients with
HSP typically show leg stiffness and gait disturbance,
decreased perception of sharp stimulation, and dimin-
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point to the corticospinal tracts, dorsal columns, and,
to a lesser extent, the spinocerebellar fibers as the struc-
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tures primarily affected by HSP. These represent the
longest axons of the central nervous system. Interest-
Hereditary spastic paraplegia (HSP) is characterized
ingly, degeneration occurs only in the distal portion ofby progressive weakness and spasticity of the lower
these structures, while sparing the neuronal cell bodieslimbs due to degeneration of corticospinal axons. We
(i.e., pyramidal neurons and sensory neurons of thefound that patients from a chromosome 16q24.3±
dorsal root ganglia) of degenerating fibers. Peripherallinked HSP family are homozygous for a 9.5 kb dele-
nerves are also normal and there are no signs of demye-tion involving a gene encoding a novel protein, named
linization (Fink, 1997; Harding, 1981; Reid, 1997).Paraplegin. Two additional Paraplegin mutations, both
Autosomal dominant, autosomal recessive, and X-linkedresulting in a frameshift, were found in a complicated
forms of HSP have been described, indicating geneticand in a pure form of HSP. Paraplegin is highly homolo-
heterogeneity (Harding, 1981; Fink, 1997; Reid, 1997).gous to the yeast mitochondrial ATPases, AFG3,
Linkage studies identified three loci for autosomal domi-RCA1, and YME1, which have both proteolytic and
nant forms, SPG3 (Hazan et al., 1993), SPG4 (Hazan etchaperon-like activities at the inner mitochondrial
al., 1994), and SPG6 (Fink et al., 1995), on chromosomesmembrane. Immunofluorescence analysis and import
14q, 2p, and 15q, respectively. One locus, SPG5 (Hentatiexperiments showed that Paraplegin localizes to mito-
et al., 1994), involved in autosomal recessive HSP haschondria. Analysis of muscle biopsies from two pa-
been mapped to chromosome 8q. The study of familiestients carrying Paraplegin mutations showed typical
in which mapping to any of these loci has been excludedsigns of mitochondrial OXPHOS defects, thus sug-
indicates the presence of additional loci for autosomalgesting a mechanism for neurodegeneration in HSP-
recessive HSP (Hentati et al., 1994). Two distinct formstype disorders.
of HSP, SPG1 and SPG2, have been assigned to the X
chromosome and found to be due to mutations in theIntroduction
L1CAM and PLP genes located on Xq28 (Jouet et al.,
1994) and Xq22 (Saugier-Veber et al., 1994), respec-Progressive weakness and spasticity of the lower limbs
are the clinical hallmarks of hereditary spastic paraple- tively. With the exception of these two forms, in which
gia (HSP) (Harding, 1981; Fink, 1997; Reid, 1997). This spastic paraplegia is part of the clinical spectrum of
complex neurological syndromes such as Pelizaeus-
Merzbacher and MASA syndromes, no genes involved9 To whom correspondence should be addressed.
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Figure 1. Homozygous Deletion Identified in
Patients from a Consanguineous Italian Fam-
ily with Autosomal Recessive HSP
(A) PCR analysis using primers c1-c2 on HSP
family 1; DNA from affected individuals failed
to amplify. One affected and two healthy
members were not available for the analysis
and were withdrawn from the pedigree struc-
ture. M,100 bp DNA molecular weight marker.
(B) Southern blot analysis of a control (C) and
patient 10 (pt10) DNA probed with the 1.1 kb
insert of EST clone 154386.
in HSP have yet been identified. The cloning of HSP genes. One of these genes, CMAR (cell adhesion mole-
cule regulator; GenBank accession number S54769),genes is a critical step in understanding the pathoge-
was originally reported as a 459 bp partially character-netic mechanisms underlying this group of disorders.
ized transcript colinear with genomic DNA and found toRecently, we mapped the locus of a new form of pure
be involved in the suppression of tumor invasion (Pullmanautosomal recessive HSP to 16q24.3 (SPG7) (De Michele
and Bodmer, 1992). A set of PCR primers, c1 and c2,et al., 1998). A 9.5 kb deletion involving a previously
were designed from the original open reading frameidentified partial transcript from 16qter was discovered
sequence (Pullman and Bodmer, 1992) and tested onin all affected individuals from a 16q24.3-linked family.
all individuals from our HSP family. As shown in FigureIn addition, two frameshift mutations, both generating
1A, the five affected individuals failed to amplify, whiletruncated forms of the protein, were found in a French
healthy sibs and parents yielded the expected PCRfamily with a complicated form of HSP and in another
product. This result was replicated with a different setItalian family with pure HSP. BLAST analysis revealed
of primers, c3 and c4, from the same transcript (datathat this gene encodes a novel protein, which we named
not shown). Consequently, a homozygous deletionParaplegin, highly homologous to a subclass of yeast
spanning this gene was hypothesized, consistent withmitochondrial metalloproteases. Immunofluorescence
the finding of a homozygous haplotype for 16qter mark-analysis in transfected COS-7 cells and mitochondrial
ers displayed by the affected individuals (De Michele etimport in vitro experiments showed a specific mitochon-
al., 1998).drial sublocalization. Analysis of muscle biopsy speci-
Several ESTs identical to the reported CMAR se-mens from two HSP patients carrying Paraplegin muta-
quence were found in dbEST, allowing us to build ations showed the presence of typical signs of OXPHOS
1.1 kb cDNA contig and extending the original 459 bpimpairment.
sequence toward the 59 end. We selected a few clones,These data demonstrate an abnormality in a nuclear-
namely, 154385, 154386 and 31543, which were rese-encoded mitochondrial protein and the presence of mi-
quenced either partially or completely (clone 154386),tochondrial OXPHOS defects in HSP, revealing the pres-
confirming the sequence data reported in dbEST. Theence of an impairment of mitochondrial function in this
entire 1.1 kb insert fragment of EST clone 154386 wasclass of progressive neurodegenerative disorders.
used as a probe on an EcoRI-restricted Southern blot
containing DNA from one patient and a control. Figure
Results 1B shows the absence of a 5.6 kb EcoRI band in the
patient DNA, thus confirming the presence of a homozy-
A 9.5 kb Deletion of Chromosome 16q24.3 in HSP gous deletion.
Recently, we described a large consanguineous Italian To determine the extent of the 16q24.3 deletion in
family affected by autosomal recessive HSP (family 1). HSP patients, an arrayed human genomic PAC library
Patients from this family showed typical features of the (Ioannou and de Jong, 1996) was probed with PCR frag-
pure form of HSP, with age of onset ranging from 25 to ments c1-c2 and c3-c4, spanning from nucleotide 2881
42 and a slow progression of symptoms. A genome- to 3016 and from 2524 to 2856 of the cDNA sequence,
wide search using a panel of 358 highly polymorphic respectively. One positive clone, 1194G18, was identi-
microsatellite markers showed linkage of the disease fied by hybridization screening and confirmed by c1-c2
locus in this family to markers on chromosome 16q24.3 and c3-c4 PCR amplification. Alu-vector-specific PCR
in a region spanning approximately 6 cM from D16S3048 primers (see Experimental Procedures) allowed us to
to the telomere (De Michele et al., 1998). This region sequence the ends of the human genomic PAC insert
and design two sets of primers at each end of the PACincluded several human ESTs as well as some known
Mitochondrial Metalloprotease Mutations in HSP
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Figure 2. Characterization of the Deleted Region
(A) Genomic map of the complex 9.5 kb deletion detected in family 1. GRAIL predicted exons are drawn proportionally to their relative
probability. Gray boxes denote coding region; open box, 39 UTR. Alu repeats are shown as striped boxes. Completely sequenced genomic
subclones are indicated by thin lines. At the bottom, black boxes indicate sequences retained in patients carrying the 9.5 kb deletion.
(B) PCR amplification of the deletion junction of family 1 using primers c113 and c114 (upper part). The 1.2 kb band is visible only in deleted
patients (pt6 and pt10). Lower part, c103-c104 PCR test to confirm the deletion; a single band is present only in the control.
clone. These sets were used to amplify patient DNA in contig of clones gHindB12 and gEco6 and containing
the deletion boundaries was sequenced. Alignment oforder to study the extent of the deleted region. Positive
reactions with both primer sets in patients and controls genomic sequences to the cDNA (see below, Cloning
of Paraplegin cDNA) identified five exons of the geneindicate that the deletion was included entirely within
the genomic region spanned by the PAC insert (data that are included in this 10.8 kb sequence (Figure 2A).
Grail 2 analysis (Roberts, 1991) of the 10.8 kb genomicnot shown). Two plasmid subclones were isolated from
two different libraries derived from PAC clones, allowing sequence suggested the presence of these five exons
and failed to show other putative exons (Figure 2A),us to build a 10.8 kb genomic contig (see Experimental
Procedures) and several primer sets were designed to indicating that a single gene is contained within this
genomic region.investigate the extent of the genomic region deleted in
patients (Figure 2A). Primers c113 and c114 (Figure 2A) were used to am-
plify the deletion junction in patient DNA. These twoThe entire 10.8 kb genomic region included in the
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primers failed to amplify control DNA due to the exces-
sive length (. 10 kb) of the target sequence, while they
amplified a 1.2 kb band in patient DNA (Figure 2B). By
aligning the sequence of this amplification product to
that of the genomic clones spanning the same area, we
were able to study the molecular rearrangement under-
lying the deletion event (Figure 2A). Control and patient
sequences are colinear from the c114 primer to the first
deletion breakpoint, which is located after 131 bp. Colin-
earity continues for 278 bp in an intron sequence be-
tween exon -3 and exon -2 and resumes again 932 bp
downstream from the end of the last exon for 308 bp.
The last breakpoint is encountered 359 bp downstream,
where the patient and control sequences are once again
identical up to primer c113 (Figure 2A). Multiple Alu re-
petitive sequences were detected throughout this geno-
mic fragment (hatched boxes in Figure 2A). These repeat
sequences may have played a role in the generation of
this complex rearrangement event.
Cloning of Paraplegin cDNA (SPG7)
A human teratocarcinoma cell line (Andrews et al., 1984)
NT2D1 cDNA library was screened using the entire 1.1
kb insert of EST clone 154386 as a probe. Four positive
clones were isolated and characterized by sequence
analysis (Figure 3A). The sequences of clones 5, 12,
13, and 15 were aligned, resulting in a 3080 bp contig
sequence, which is entirely covered by clone 5. Clone
13 was found to be rearranged at its 59 end, continuing
with an Alu sequence. A long open reading frame of
2390 bp was identified, starting at the 59 end of clone
5 and ending with a stop codon signal, followed by a
687 bp 39 untranslated sequence.
To clone the missing start codon and 59 untranslated
region (UTR) of Paraplegin mRNA, two different sets of
Figure 3. Characterization of Paraplegin Transcript
RACE experiments were performed onhuman fetal brain
(A) cDNA clones isolated from NT2D1 library and RACE-PCR prod-
and human fetus cDNAs (see Experimental Procedures). ucts (hf, total human fetus cDNA; hfb, human fetal brain cDNA)
Both experiments yielded a 658 bp fragment (RACE spanning the full-length Paraplegin cDNA. All clones end after the
standard primer-pr1), which was directly sequenced same polyadenylation signal.
(B) Open reading frame map of Paraplegin cDNA. Short vertical bars(Figure 3A). The two sequences were consistent with
denote possible translation start sites; long bars, stop codons. Thethat obtained from cDNA clones and extended upstream
Paraplegin coding region is in gray.from the sequence of clone 5 by 15 additional nucleo-
(C and D) Northern blots of human fetal (C) and adult (D) tissue
tides, including the putative ATG start codon imbedded RNAs probed with the full-length Paraplegin cDNA.
in the canonical Kozak consensus sequence AACATGG
(Kozak, 1989). The sequence surrounding the putative
initiation codon was confirmed on the genomic clone
region of the SPG7 gene spanning nucleotides 2619±gHindC12 obtained through the screening of a HindIII
3078. This conclusion is based on several lines of evi-minilibrary probed with oligonucleotide pr2.
dence. First, a sequence 100% identical to the pre-The full-length cDNA sequence of this gene, which
viously reported CMAR sequence is found in over 30was named SPG7, measures 3087 nucleotides with a
different SPG7 cDNA clones, including ESTs, identifiedvery short 59 UTR, encoding a predicted protein (Para-
from at least 10 different cDNA libraries (data notplegin) of 795 amino acids, and has a 690 bp 39 UTR
shown). Second, CMAR maps to a single locus in the(Genbank-EMBL accession number Y16610). The size
human genome, which is also identified by SPG7 cDNA,of the cDNA sequence is consistent with the data ob-
as shown by Southern analysis using several restrictiontained by Northern analyses, which showed an appar-
enzymes (data not shown). Third, the CMAR probe iden-ently ubiquitous transcript of approximately 3.2 kb in all
tifies the same deletion recognized by SPG7 cDNA infetal and adult tissues tested (Figures 3C and 3D). Two
our HSP patients. Fourth, the CMAR probe shows theadditional hybridizing transcripts of approximately 2.6
same size transcript as SPG7 on Northern analysis (dataand 7.5 kb were detected in heart and pancreas.
not shown).Based on our data, the CMAR gene, previously de-
No data on the endogenous CMAR protein are foundscribed as a 459 bp transcript colinear with genomic
DNA (Pullman and Bodmer, 1992), is part of the 39 UTR in the literature. In addition, the CMAR putative protein
Mitochondrial Metalloprotease Mutations in HSP
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affected sibs from this family are homozygous for an A
insertion at position 2228 of the SPG7 cDNA, while their
mother is heterozygous for the same mutation. This in-
sertion creates a frameshift and a stop codon only two
amino acids downstream, resulting in a truncated form
of Paraplegin that is missing 57 amino acids at the C
terminus.
Paraplegin Is Homologous to YeastFigure 4. Frameshift Mutation in a French Family with Complicated
Autosomal Recessive HSP Mitochondrial Metalloproteases
Affected individuals from family 2 are homozygous for a 2228insA The nucleotide and predicted amino acid sequences of
mutation, while the mother, the obligate carrier, is heterozygous. Paraplegin were compared with the GenBank and EMBL
databases by both BLASTX and TBLASTN algorithms
(Altschul et al., 1990), which yielded similar results. The
product is not conserved in primates, based on se- highest similarity was obtained with protein belonging
quence analysis of genomic DNA, as major insertions to the AAA family (ªAAAº for adenosine triphosphatases
and deletions and scattered point mutationswere identi- associated with diverse cellular activities [Confalonieri
fied in several species (Durbin et al., 1997). Last, and and Duguet, 1995]). In addition, homology was also de-
most importantly, two frequent insertion/deletion poly- tected with the 59 UTR of the murine protein kinase Vik
morphisms in the predicted CMAR coding region were (variant in kinase) gene (Kelman et al., 1993). From our
identified in normal individuals (Koyama et al., 1993; results it is clear that the original Vik cDNA clone re-
Durbin et al., 1994). Both of these polymorphisms result ported by Kelman et al. was chimeric, containing a por-
in major changes in the CMAR putative protein product. tion of the murine Paraplegin sequence at its 59 end.
These observations suggest that the original CMAR This conclusion is also supported by the nonsyntenic
cDNA clone may not encode a protein in vivo and that mapping assignments of the Vik and Paraplegin loci.
functional data obtained using CMAR cDNA in transfec- The AAA family consensus sequence is found be-
tion experiments may be due to artifactual translation tween amino acids 344 and 534 of the Paraplegin poly-
of a peptide encoded by the CMAR sequence. peptide (Figure 5A). Paraplegin showed particularly
striking homology to a subclass of the AAA proteins,
Identification of Additional Paraplegin Mutations specifically to the yeast metalloproteases AFG3, RCA1,
To confirm the involvement of SPG7 in HSP, we searched and to a lesser extent, YME1 (GueÂ lin et al., 1994; Pajic
for mutations in patients from additional HSP families et al., 1994; Schnall et al., 1994; Tzagoloff et al., 1994)
and sporadic cases. We tested a total of 14 unrelated (Figure 5A), showing 55%, 55%, and 52% amino acid
HSP patients for mutations in 10 exons of the SPG7 identity, respectively. These are yeast mitochondrial
gene, using partial gene structure information available proteins with both proteolytic and chaperon-like activi-
to us. Patient genomic DNA was amplified using sets ties. Functional domains of these mitochondrial pro-
of primers flanking intron/exon boundaries, and PCR teins, the ATP-binding motif GPPGCGKTand theHEXXH
products were used in single strand conformation poly- motif typical of a zinc-dependent binding domain, are
morphism (SSCP) analysis (see Experimental Proce- completely conserved in Paraplegin (Figure 5A). The ho-
dures). The exons tested span approximately 60% of mology between Paraplegin and this mitochondrial sub-
the coding region. class of AAA proteins is not limited to these known
Two additional mutations were identified. The first functional domains but spans almost the entire protein
mutation was found in a recessive family from a small (Figure 5A). No vertebrate homolog of these proteins
village insouthern Italy with two affected brothers (family has been described so far. Figure 5B shows the compar-
2), who show typical signs of pure HSP with an age of ison of thehydrophobicity plot of human Paraplegin with
onset of 26 years. A 2 bp deletion (784del2) was found those of yeast AFG3 and RCA1. The three hydropho-
in the available patient. This mutation causes a frame- bicity patterns are all very similar. However, the Para-
shift that abolishes approximately 60% of the protein. plegin pattern appears to resemble more closely that of
The patient is homozygous for this mutation and con- AFG3 rather than RCA1.
sanguinity, even though not reported by anamnestic
data, is very likely.
The second mutation was found in a French family in Paraplegin Localizes to Mitochondria
Computer analysis of Paraplegin leader peptide usingwhich HSP segregates as an autosomal recessive trait
(family 3, Figure 4). Interestingly, patients fromthis family the PSORT program (Uberbacher and Mural, 1991),
which allows the prediction of protein localization sites,are affected by a complicated form of HSP with a mean
age of onset of 34 years. They showed progressive suggests a mitochondrial localization of Paraplegin pro-
tein. MitoProt (Claros and Vincens, 1996) analysis pre-weakness and spasticity of the lower limbs, decreased
perception of sharp stimulation, diminished vibratory dicts a high probability (0.93) of export to mitochondria
and a probable cleavage site at position 49. The helicalsense, and urinary incontinence, which are typical signs
of HSP. In addition, these patients also had optic atrophy wheel pattern (an amphiphilic structure composed of
basic residues, mainly arginine, on one side and apolar(3 out of 3 examined), cortical atrophy (1 out of 3 exam-
ined), and cerebellar atrophy (2 out of 3 examined). All residues on the opposite side) of the N-terminal region
Cell
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Figure 5. Protein Homology and Hydrophobicity of Paraplegin
(A) CLUSTAL W multiple alignment of the yeast proteins AFG3, RCA1, and YME1 and Paraplegin. The AAA protein family consensus sequence
is underlined. The HEXXH domain is marked by a dashed line.
(B) Kyte-Doolittle hydropathy plots of AFG3, RCA1, and Paraplegin. Pattern comparison shows strong similarity between AFG3 and Paraplegin.
of Paraplegin suggests the presence of typical mito- cDNA was transcribed and translated in vitro using T3
RNA polymerase and a reticulocyte lysate preparationchondrial leader sequences (data not shown). This is
in the presence of [35S]methionine. A single major bandalso supported by the biochemical characteristics of the
was obtained by in vitro translation of the gene. Radiola-leader peptide, showing a primary sequence enriched
beled translation product was incubated with freshlyin hydrophobic and basic residues. Among the first 41
prepared mitochondria either fully coupled or previouslyamino acids, the basic residues are all arginines (high
exposed to valinomycin, a powerful uncoupler. Whenratios of arginine to lysin are typical of leader peptide)
the translation product of human Paraplegin cDNA was(Neupert et al., 1990) and no acidic residues are present.
added to coupled mitochondria, a second shorter bandIt is worth noting that the submitochondrial localization
was obtained in addition to the band corresponding toof Paraplegin onto the inner membrane is consistent
the native (precursor) protein. The shorter band corre-with the same localization of AFG3 and RCA1 in yeast
sponds to the mature protein in which the N-terminalmitochondria.
mitochondrial leader peptide has been cleaved off. Pro-The full-length cDNA was assembled using a PCR-
tein internalization into mitochondria was then assayedcloning strategy, basically by adding the 59 sequence
by exposure to trypsin. The precursor protein was com-obtained from RACE experiments to clone 5 (see Experi-
pletely digested by exposing mitochondria to trypsin,mental Procedures), since all of the isolated cDNA
while the mature protein was protected. This result dem-clones lacked the 59 end. The complete coding region
onstrates that the mature protein was internalized withinof Paraplegin was cloned into a modified pMT21 expres-
the inner mitochondrial compartment, which is imper-
sion vector, in frame at its 39 end with the c-myc immu-
meable to trypsin and other proteases. When mito-
nogenic sequences, in order to produce a Paraplegin±
chondria were preincubated with the OXPHOS uncou-
c-myc fusion protein. pler valinomycin, radiolabeled proteins were completely
Transfected COS-7 cells were also used to perform digested by trypsin due to inhibition of the energy-
immunofluorescence analysis. Figure 6A shows a side- dependent protein transport into mitochondria.
by-side comparison of the immunofluorescence pattern The sizes of the precursor versus mature proteins,
of pMTparac-myc transfected COS-7 cells treated with deduced from the autoradiograph of Figure 6B, indi-
anti-c-myc antibody and of the same cells treated with cates molecular weights of 89 and 81 kDa, respectively.
the anti-mtSSB antibody recognizing the mitochondrial These values are consistent with the predicted size of
protein SSB (single strand binding protein). In both the Paraplegin native polypeptide (88 kDa) and with a
cases, a granular cytoplasmatic pattern with higher den- mitochondrial targeting sequence encompassing the
sity around the nucleus was observed. This pattern is first 40±50 residues on the amino terminus. Two poten-
specific to mitochondrial proteins. No signals were tial cleavage sites, based on the ªR-2 ruleº (Claros and
found in the cytoplasm or in the nucleus in spite of the Vincens, 1996), are present between amino acids 40±41
strong expression system (i.e., COS-7 cells and pMT and 48±49.
vector) used in the experiments. This indicates an exclu-
sive mitochondrial localization. Mitochondrial OXPHOS Defect in HSP
The autoradiography reported in Figure 6B shows the Needle muscle biopsies were taken under informed con-
sent from the left quadriceps of patients 9 and 11, tworesults of an in vitro mitochondrial import assay. SPG7
Mitochondrial Metalloprotease Mutations in HSP
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Figure 6. Paraplegin Subcellular Localization
(A) Immunofluorescence staining of COS-7 cells transfected with
pMTparac-myc. On the left, fluorescein-specific immunostaining (485
nm) by anti-c-myc MAb 9E10; on the right, rhodamine-specific im-
munostaining (546 nm) of the same cells by a polyclonal antibody
against the mtSSB. Paraplegin colocalizes with mtSSB specifically
into mitochondria.
(B) Mitochondrial import in vitro. Lane 1, translation product of full-
length Paraplegin; lane 2, same as lane 1, loading 1/10; lane 3, in
the presence of mitochondria; lane 4, in the presence of mitochon-
dria and trypsin 500 mg/ml; lane 5, in the presence of mitochondria
and trypsin 250 mg/ml; lane 6, in the presence of mitochondria,
trypsin 500 mg/ml, and valinomycin.
Figure 7. Histological, Histoenzymatic, and Ultrastructural Analyses
of Skeletal Muscle Biopsy
(A) Trichrome-stained section of muscle biopsy from patient 11severely affected individuals of family 1. Morphological
showing a typical ragged-red fiber. Magnification 2503.
and histoenzymatic examination revealed the presence (B and C) Consecutive cryosections of muscle biopsy from patient
of several ragged-red fibers in both samples, which also 11 stained for SDH (B) and COX (C). An SDH strongly reactive fiber
appeared intensely stained at the histoenzymatic reac- and an SDH normally reactive adjacent fiber are both COX negative.
Magnification 2503.tion to succinate dehydrogenase (SDH) (Figures 7A and
(D) Electron micrograph of a ragged-red fiber from patient 11. The7B).The ragged-red, intensely SDH-stained areasreflect
subsarcolemmal space is packed with abnormal mitochondria. Mostexcessive proliferation of subsarcolemmal and inter-
of the organelles contain paracrystalline inclusions arrayed to pro-
myofibrillar mitochondria as an ineffective mechanism duce a ªparking-lotº pattern. Magnification 10,0003.
to compensate an OXPHOS defect. In support of this
view, examination of serial muscle sections showed that
Cell
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the ragged-red, intensely SDH-positive fibers, as well The identification of a 9.5 kb homozygous deletion
as other fibers that appeared morphologically normal, including the last 5 exons of the SPG7 gene in a consan-
had no reaction to cytochrome c oxidase, the fourth guineous HSP family suggested the involvement of this
complex of the mitochondrial respiratory chain (Figure gene in HSP. Definitive evidence of involvement of the
7C). The ªCOX-deficient fiberº is the histochemical sig- SPG7 gene in HSP came from the identification of point
nature of most mitochondrial disorders and thus indi- mutations in different patients, each resulting in major
cates a localized defect of OXPHOS (Dubowitz, 1985). abnormalities of Paraplegin polypeptide. A total of 14
Electron microscopy examination of a ragged-red fi- additional HSP index cases were tested for mutations
ber showed the presence of subsarcolemmal accumula- in 10 exons of the SPG7 gene. Two frameshift mutations
tion of mitochondria of bizarre shape, with hyperplastic were identified in an Italian and a French family. Interest-
cristae and paracrystalline inclusions producing typical ingly, patients from the French family are affected by a
ªparking-lotº structures within numerous organelles (Fig- complicated form that shows, in addition to the typical
ure 7D). Less severe changes, i.e., scattered COX-defi- signs of HSP, also optic atrophy, cortical atrophy, and
cient fibers with no mitochondrial accumulation, were cerebellar atrophy. This multisystem involvement is in-
found in two muscle biopsies taken from two mildly triguing as it resembles that of mitochondrial disorders.
affected individuals, patients 6 and 10 (data not shown). Considering that only 60% of the coding region was
tested, the finding of three independent mutations
Discussion among 14 HSP patients tested suggests that Paraplegin
defects may be a common cause of HSP. The possibility
Mitochondrial biogenesis and function requires the con- that Paraplegin defects may also be involved in autoso-
certed action of both organelle and nuclear genome mal dominant forms of HSP, due to dominant-negative
encoded molecules (Shoffner and Wallace, 1995; Zevi- mutations, must be considered in light of the observa-
ani et al., 1997). We have identified a novel nuclear- tion that Paraplegin-related molecules in yeast (AFG3
encoded mitochondrial protein, named Paraplegin. This and RCA1) form multimeric complexes (Arlt et al., 1996).
molecule is highly homologous to a mitochondrial sub- These data demonstrate a mitochondrial protein de-
class of yeast ATPases. Members of this subclass are fect in HSP. Among several hypotheses made on the
the ATP-dependent metallopeptidases AFG3, RCA1, pathogenetic mechanisms underlying HSP, a mitochon-
and YME1 (also known as Yta10p, Yta12p, and Yta11p,
drial involvement has never been postulated before. Ho-
respectively), originally identified by genomic sequenc-
mology between Paraplegin and yeast mitochondrial
ing and complementation studies in yeast (GueÂ lin et al., proteins and localization of Paraplegin to mitochondria
1994; Pajic et al., 1994; Schnall et al., 1994; Tzagoloff
prompted us to analyze the patients' mitochondria. The
et al., 1994). Paraplegin represents the first vertebrate
finding of morphological and functional abnormalities
homolog of this class of proteins described so far.
typical of mitochondrial OXPHOS defects in muscleIn yeast, AFG3 and RCA1 form a membrane-embed-
biopsy specimens of patients from the family carryingded complex that has both a protease activity, needed
a deletion of the SPG7 gene provides an important cluefor ATP-dependent degradation of mitochondrial trans-
to the pathogenesis of HSP. Interestingly, in this familylation products, and a chaperon-like function, mediating
the severity of the cellular phenotype appears to corre-assembly of membrane-associated ATP synthase (Arlt
late with the severity of the symptoms, as the two pa-et al., 1996). The correct folding and assembly of these
tients with the most compromised neurological pheno-proteins is needed for functional respiratory chain pro-
type also showed a higher percentage of pathologicalcesses (Paul and Tzagoloff, 1995). Yeast strains carrying
muscle fibers.mutations in either AFG3, RCA, or YME1 genes are de-
As in other mitochondrial diseases, the clinical spec-ficient in the assembly of functional respiratory and
trum of Paraplegin defects is variable, with some pa-ATPase complexes (Tauer et al., 1994; Paul and Tzago-
tients having pure forms with exclusive involvements ofloff, 1995; Rep et al., 1996b).
specific axonal populations, while others have multisys-We demonstrated that Paraplegin localizes to mito-
temic forms (Shoffner and Wallace, 1995). At this point,chondria. This is based on several lines of evidence.
we cannot explain why a defect in an apparently ubiqui-First, computer analysis of Paraplegin sequence pre-
tous protein required for mitochondrial function affectsdicts the presence of a mitochondrial targeting peptide
primarily specific axonal populations such as the corti-in the amino terminus of the protein (data not shown).
cospinal tracts and the dorsal columns. These are theSecond, immunofluorescence studies on transfected
longest axons in the human body and may be moreCOS-7 cells showed a fine granular pattern in the cyto-
sensitive to an impairment of the mitochondrial proteinplasm, more intense in the perinuclear region, typical of
degradation machinery.mitochondrial proteins such as SSB, which colocalizes
Another autosomal recessive neurodegenerative dis-with Paraplegin (Figure 6A). No signal was observed
order due to mutations in a mitochondrial protein isin other cell structures, indicating that the protein was
Friedreich ataxia (FA). This disease, besides presentingtargeted only to mitochondria. Last, energy-dependent
many clinical analogies with HSP, is due to a defect inmitochondrial targeting and cleavage were demon-
Frataxin, a mitochondrial protein involved in ironhomeo-strated by experiments of mitochondrial import and
stasis and respiratory function (Gray and Johnson, 1997;trypsin-protection assays in vitro. Together, sequence
Rotig et al., 1997). A defect of iron-dependent mitochon-identity values (Figure 5A), comparison of the hydropho-
drial enzymes, including some respiratory complexes,bicity plots (Figure 5B), and subcellular localization stud-
has recently been demonstrated in two FA patientsies (Figures 6A and 6B) suggest that Paraplegin function
in human is similar to that of AFG3 in yeast. (Rotig et al., 1997).
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AGCCACCGCACCCAGCC) were used in PCR amplification. The op-Compromised chaperon or protease functions were
posite insert end was obtained by subcloning the entire PAC DNAsuggested as mechanisms promoting aggregation and
(HindIII restricted) into a plasmid minilibrary. The clone containingnucleation in neurodegenerative disorders (Lansbury,
the insert end was isolated from the minilibrary by probing with a
1997). However, no defects in specific proteins having vector-specific fragment (PCR fragment PAC1, TAGTCAATTCGGG
such functions have been found in human diseases. AGGATCG; and PAC2, CTGCCAGAAGTGCAGTCGTA).
HSP may be the first example of this class of disorders.
Southern and Northern BlotsIn yeast, many of the factors involved in the biogenesis
Southern blot analysis was performed by loading 7 mg of genomicof mitochondrial respiratory chain are known to cooper-
DNA using standard protocol (Sambrook et al., 1989). Fetal tissuesate, having partially overlapping roles. For instance, in-
Northern blot, containing 2 mg per lane of polyA1 RNA, was pur-
activation of either AFG3 or RCA1 genes can be comple- chased from Clontech (Palo Alto, CA) and hybridized using standard
mented by overexpression of the LON gene (Rep et al., protocol (Sambrook et al., 1989).
1996a). In the case of HSP, it is possible that other
Cloning and Sequencing the Deletion Regionmitochondrial factors with a similar function can com-
The human arrayed genomic library RPCI-5 was previously reportedpensate Paraplegin defects, at least in part, thus reduc-
(Ioannou and de Jong, 1996). To perform a fine characterization ofing the severity of symptoms. As in yeast (Pajic et al.,
the deletion breakpoints, two plasmid-based minilibraries of the
1994), defects in Paraplegin may cause an accumulation PAC insert (EcoRI and HindIII restricted) were generated, and 96
of incompletely synthesized mitochondrial translation clones from each minilibrary were harvested and arrayed in microti-
products and nonassembled subunits of ATP-synthase ter plates to facilitate subsequent screening experiments. A first
PCR screening was performed with primers c1-c2 and one cloneor respiratory chain complexes, leading to axonal de-
was selected: gEco6 from the EcoRI minilibrary. A PCR probe wasgeneration. The decline of mitochondrial OXPHOS activ-
prepared at the extremity of gEco6 (primers c103, ACTGAAACTTACity and the increase of mitochondrial mutations oc-
GTGTTCCATAC; and c104, ACTGACAAAACATTGGTAATTG) and
curring with aging may contribute to the progressive used to screen the HindIII minilibrary, thus isolating clone gHindB12,
nature of HSP phenotype. partially overlapping gEco6 (see Figure 2A). The deletion region was
The discovery of Paraplegin illustrates once again how entirely sequenced by primer walking on an automated ABI 377 (PE-
Applied Biosystems). Manual sequencing was performed on PCRthe cloning of a disease gene and its comparison to
fragments using the fmol DNA Sequencing System (Promega).other species such as yeast may facilitate the under-
standing of pathogenetic mechanisms underlying hu-
cDNA Cloningman disease. Contrary to most mitochondrial disorders,
The human NT2D1 retinoic acid differentiated cDNA library (Stra-
here the mitochodrial defect was found after the identifi- tagene catalog number 937233, LaJolla, CA) was plated at 2.5 3
cation of the gene. Impairment of mitochondrial function 104 and 5 3 104 plaque forming units/140 mm plate and screened
under standard conditions (Sambrook et al., 1989). 59 RACE-PCRmay be a common mechanism in HSPs, and it is tempt-
(Frohman et al., 1988) was performed on human fetal brain anding to speculate that it may also be involved in other
human fetus mRNA with two commercial kits, Marathon Ready (cat-progressive neurodegenerative diseases. Along this line
alog numbers 7402-1 and 7438-1, Clontech, Palo Alto, CA), followingof reasoning, additional human homologs of yeast mito-
the manufacturer's recommendations and using pr1, CCAGGGTGC
chondrial ATPases, or members of the same functional AGGTAGACTTC, as specific primer.
networks, should be considered candidate genes for
this class of disorders. Mutation Detection
The 2 bp deletion mutation, 784del2, is located on exon 6 of theThe datapresented in this paper may also have clinical
SPG7 gene and was detected in family 2 by PCR-SSCP with primersimplications. The finding of mitochondrial abnormalities
aa16, TGTGCCTGCCTCTCTTTCTT, and aa13, ACCAGAAAGAGTTCin muscles from HSP patients suggests that muscle
AGAGAGC. The 2228insA mutation detected in family 3 lies on the
biopsy can be a useful diagnostic tool for HSP and last exon coding region, which was amplified by primers aa9, ACAT-
possibly for other similar neurodegenerative disorders GCATATGCCTGTTCTTTC, and c8, AGCGACAGAGGCCAACAGT
as well. Ultimately, the knowledge derived from yeast AAC (312 bp). SSCP analysis (Orita et al., 1989) was performed
on 6% polyacrylamide 10% glycerol gels (60:1 acrylamide to bis-on the putative function of Paraplegin may open up new
acrylamide). PCR fragments were internally labeled by incorporatingpossibilities for the development of therapeutic strate-
0.1 ml of 32Pa-dCTP (3000 Ci/mmol).gies for HSP.
pMTparac-myc Expression Construct
Clone 5 was replaced at its 59 end by the PCR fragment obtainedExperimental Procedures
by primer muATG2, GCGAATTCAGGCCAACATGGCCGTGCTGCTG
CTGCTG, introducing an EcoRI site upstream from the endogenousOligonucleotide Primers
ATG start codon and c34Bam, TGGGATCCTGTCCTTGGCC, andPCR reactions were performed in a final volume of 20 ml in standard
restricted by EcoRI and HindIII (naturally occurring at position 688).conditions and using the following primers (as indicated in the Re-
The 39 end of modified clone 5, named BS-Paraplegin, was replacedsults section): c1, TAGACAGTCGTTCCCAGTGT; c2, AAACCAAGGC
by the BstEII (position 1974)±XhoI restricted PCR fragment obtainedATCCCCAACA; c3, GACTTCTGAGATCTGTTGATTG; c4, TGGAGAT
with c20, GCAATGAGGCTGCGCTGCA, and mu-stopX, ctccctcgagcAGGACAATCGGC; c101, TGTGAGACACGTTTGCAGCG; c106, AAT
CTTGGGCCAAGTCGGCTCTTC, deleting thenatural stop codon andGTTCTAAATGGATGGGAGG; c109, GATCCAGAAAGTGATGGGGA;
introducing an XhoI site. A 2400 bp EcoRI±XhoI fragment was clonedc111, GCCTCCTGCTTACTTTCCCTCT; c113, GGTACCCGACTGAA
into a modified pMT21 vector containing the c-myc epitope (a giftAATGTC; c114, GGGAGAGGGAAAGTAAGCAG; pr2, GAGGCCTGCT
of M. Tessier-Lavigne), thus obtaining pMTparac-myc.GGCCATGTAC.
COS-7 Transfection and Western Blot
Transient transfection of pMTparac-myc into COS-7 cells was per-Cloning the PAC Insert Ends
To clone one PAC insert extremety, a vector-specific primer (PAC3, formed with lipofectamine (GIBCO BRL) according to the manufac-
turer's instructions. Undiluted supernatant of monoclonal antibodyGGCACCTGTCCTACGAGTTG; flanking the BamHI cloning site of
pCYPAC2) and the Alu repeat±specificprimer (AluPrimer, AGGAGTG anti-c-myc 9E10 (Evan et al., 1985) was used as primary antibody.
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Immunocytochemistry DuÈ rr, A., Brice, A., Serdaru, M., Rancurel, G., DerouesneÂ , C., Lyon-
Caen, O., Agid, Y., and Fontaine, B. (1994). The phenotype of ªpureºTransfected cells were washed in PBS, fixed in 4% paraformalde-
autosomal dominant spastic paraplegia. Neurology 44, 1274±1277.heide/PBS for 30 min, blocked for 60 min in PBS, 10% porcine
serum, and 0.2% Triton X-100, incubated 120 min with primary anti- Evan, G.I., Lewis, G.K., Ramsay, G., and Bishop, J.M. (1985). Isola-
bodies, anti c-myc 9E10 and anti-mtSSB, diluted 1:200 (Tiranti et tion of monoclonal antibodiesspecific for human c-myc proto-onco-
al., 1993) in PBS/1% porcine serum/0.1% Triton X-100. Cultures gene product. Mol. Cell. Biol. 5, 3610±3616.
were then washed twice with PBS and incubated with 1:200 FITC- Filla, A., De Michele, G., Marconi,R., Bucci, L., Carillo, C., Castellano,
conjugated anti-mouse secondary antibody (for anti-c-myc) and A.E., Iorio, L., Kniahynicki, C., Rossi, F., and Campanella, G. (1992).
1:200 TRITC-conjugated anti-rabbit antibody (for anti-mtSSB) in Prevalence of hereditary ataxias and spastic paraplegias in Molise,
PBS, 1% porcine serum, and 0.1% Triton X-100. Cells were washed a region of Italy. J. Neurol. 239, 351±353.
twice in PBS and coverslipped in Vectashield (DBA). Cultures were
Fink, J.K. (1997). Advances in hereditary spastic paraplegia. Curr.viewed on a Zeiss Axioplan microscope under epifluorescence
Opin. Neurol. 10, 313±318.optics.
Fink, J.K., Wu, C.-t.B.,Jones, S.M., Sharp, G.B., Lange, B.M., Lesicki,
A., Reinglass, T., Varvil, T., Otterud, B., and Leppert, M. (1995).Mitochondrial In Vitro Export
Autosomal dominant familial spastic paraplegia: tight linkage toIn vitro transcription and translation was performed using the TNT
chromosome 15q. Am. J. Hum. Genet. 56, 188±192.Lysate Coupled Transcription/Translation kit (Promega) in the pres-
Frohman, M.A., Dush, M.K., and Martin, G.R. (1988). Rapid produc-ence of 40 mCi [35S]methionine (Amersham) (specific activity 1000
tion of full-length cDNAs from rare transcripts: amplification usingCi/mmole), as previously described by Tiranti et al. (1997).
a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci.
USA 85, 8998±9002.Histologic, Histoenzymatic, and Ultrastructural Studies
Gigli, G.L., Diomedi, M., Bernardi, G., Placidi, F., Marciani, M.G.,of Muscle Biopsies
Calia, E., Maschio, M.C.E., and Neri, G. (1993). Spastic paraplegia,Standard techniques (Dubowitz, 1985) were used for histological,
epilepsy, and mental retardation in several members of a family: ahistochemical, and electron microscopy studies.
novel genetic disorder. Am. J. Med. Genet. 45, 711±716.
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